The interactome of the N-terminus of band 3 regulates red blood cell metabolism and storage quality
Band 3 (anion exchanger 1; AE1) is the most abundant membrane protein in red blood cells, which in turn are the most abundant cells in the human body. A compelling model posits that, at high oxygen saturation, the N-terminal cytosolic domain of AE1 binds to and inhibits glycolytic enzymes, thus dive...
Saved in:
Published in | Haematologica (Roma) Vol. 106; no. 11; pp. 2971 - 2985 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
Fondazione Ferrata Storti
01.11.2021
Ferrata Storti Foundation |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Band 3 (anion exchanger 1; AE1) is the most abundant membrane protein in red blood cells, which in turn are the most abundant cells in the human body. A compelling model posits that, at high oxygen saturation, the N-terminal cytosolic domain of AE1 binds to and inhibits glycolytic enzymes, thus diverting metabolic fluxes to the pentose phosphate pathway to generate reducing equivalents. Dysfunction of this mechanism occurs during red blood cell aging or storage under blood bank conditions, suggesting a role for AE1 in the regulation of the quality of stored blood and efficacy of transfusion, a life-saving intervention for millions of recipients worldwide. Here we leveraged two murine models carrying genetic ablations of AE1 to provide mechanistic evidence of the role of this protein in the regulation of erythrocyte metabolism and storage quality. Metabolic observations in mice recapitulated those in a human subject lacking expression of AE11-11 (band 3 Neapolis), while common polymorphisms in the region coding for AE11-56 correlate with increased susceptibility to osmotic hemolysis in healthy blood donors. Through thermal proteome profiling and crosslinking proteomics, we provide a map of the red blood cell interactome, with a focus on AE11-56 and validate recombinant AE1 interactions with glyceraldehyde 3-phosphate dehydrogenase. As a proof-of-principle and to provide further mechanistic evidence of the role of AE1 in the regulation of redox homeo stasis of stored red blood cells, we show that incubation with a cell-penetrating AE11-56 peptide can rescue the metabolic defect in glutathione recycling and boost post-transfusion recovery of stored red blood cells from healthy human donors and genetically ablated mice. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Disclosures Source data for all the figures and analyses in this study are included within Online Supplementary Table S1, divided by figures and experiments. Contributions ADA and KCH are founders of Omix Technologies Inc. and ADA is a founder of Altis Biosciences LLC. AD and JCZ are consultants for Rubius Therapeutics. ADA is an advisory board member for Hemanext Inc. and FORMA Therapeutics Inc. None of the other authors has any conflicts of interest relevant to this study to disclose. ADA, JCZ, SCR and ADO designed the study. AI, JR and EZE performed structural studies. AI, ZD and KCH performed crosslinking proteomics studies. AH and JCZ performed mouse studies. ADA performed metabolomics analyses. AI, MD and KCH performed proteomics analyses; DR and SP enrolled and characterized the band 3 Neapolis patient investigated in the human studies. GP and MPB directed the REDS-III RBC Omics study and related analysis of genome-wide association studies. AI, JCZ and ADA analyzed data. ADA prepared the figures, wrote the first draft of the manuscript and revised it. All the authors contributed to the finalization of the manuscript. Data sharing statement |
ISSN: | 0390-6078 1592-8721 1592-8721 |
DOI: | 10.3324/haematol.2020.278252 |